Mal-C5-N-bis

Mal-C5-N-bis (PEG2-C2-acid) is a heterobifunctional linker used to construct antibody-drug conjugates (ADCs) for targeted cancer therapy. It enables stable linkage between antibodies and cytotoxic payloads, facilitating research in ADC development for both in vitro and in vivo preclinical studies.